E2 - Endocrine Pancreas Flashcards

1
Q

What are the exocrine functions of the pancreas?

What proportion?

A

Majority of pancreas; digestive enzymes produced and pushed into the main pancreatic duct secreted into the duodenum of the small intestine to break down carbohydrates, proteins and lipids in the chyme.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How are the endocrine cells/Islets of Langerhans localised in the pancreas?
What proportion of the pancreas?

A
  • Clustered/scattered throughout the whole pancreas in small clusters of cells.
  • 1-2% of total pancreatic mass but receive 10% of blood supply (well vascularised); hormones made need to travel in blood circulation to target tissue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the different islet cell types and their proportions?

A
α - glucagon (30-40%)
β - insulin (50-60%)
δ - somatostatin (5-10%; inhibitory) 
PP - pancreatic polypeptide (1-5%)
ε (epsilon) - ghrelin (
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the strutucre of insulin?

A

Made up of two chains:
- A-chain of 21AAs
- B-chain of 30AAs
> 2 inter-chain disulfide bonds between A- and B-chains
> 1 intra-chain disulfide bond within A-chain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Why is the half-life of insulin only 5-9 minutes?

A

Travels in circulation as free hormone (peptide); subject to degradation by proteases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How many AAs is proinsulin and how does it differ in structure from the finished insulin product?

A
  • 86AA
  • Features a connecting peptide (C-peptide) between A- and B-chains 35 AAs in length; reduces to 31 AAs in length once cleaved (31, 32, 64, 65 AA cleaved)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What happens to the C-peptide once cleaved?

A

It is packaged along with insulin into secretory granules in a 1:1 ratio (though thought to have no biological activity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the steps of insulin biosynthesis?

A
  • Insulin gene transcribed to mRNA, mRNA translated into protein
  • Preproinsulin synthesis featuring pre signal peptide, which is cleaved as preproinsulin travels through RER stack to give proinsulin
  • Proinsulin transferred from RER to Golgi (processing plant) via micro-vesicles
  • Golgi cleaves C-peptide as part of processing to give insulin
  • Insulin then packaged into secretory granules
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which 3 enzymes are involved in C-peptide cleavage of proinsulin?

A
  • Proconvertase 1 (PC1); cleaves at 32 - 33 (leaving 31 and 32 hanging on B-chain)
  • Proconvertase 2 (PC2); cleaves at 65-66 of A-chain
  • Carboxypeptidase H (CPH) removes additional 31 & 32 hanging on B-chain via degradation
  • CPH also removes 64 and 65 of C-peptide to give the 31AA C-peptide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What does cleavage of the C-peptide do to the solubility of insulin?

A

Makes it less water-soluble; so much so that it starts to precipitate in the secretory granule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the net effect of insulin precipitation in the secretory granule and the ratio that it occurs?

A

Precipitates of a ration 2 Zn2+:6 insulins; forming densely packed crystalloid core (packing a lot of insulin in a small amount of space)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How is insulin release from the β cell?

A

Exocytosis; secretory granule fuses with plasma membrane and insulin expulsion occurs (requires Ca2+ influx and ATP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Is insulin released at low blood glucose (

A

A basal level of insulin is secreted.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the events that take place in the β-cell when glucose levels > 5mmol/L?

A
  1. ) Glucose metabolised by oxidative phosphorylation pathway
  2. ) Ratio of ATP:ADP regulates ATP-sensitive K+ channels; glucose metabolism makes ATP from ADP phosphorylation (increased ATP, decreased ADP) thus increase ATP:ADP ratio closes ATP-sensitive K+ channel (normally open and allows K+ to leave cell in low ATP:ADP ratio/basal glucose levels)
  3. ) Closure of ATP-sensitive K+ channels results in build-up of +ve charge inside cell = membrane depolarisation
  4. ) Depolarisation results in activation of VGCC (voltage-gated calcium channels) opening; Ca2+ influx
  5. ) Increase in intracellular Ca2+ results in increased excocytosis and therefore insulin release
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How else is insulin release regulated apart from the main OG glucose stimuli?

A
  • AAs and fatty acids also regulate ATP:ADP ratio pathway/ATP-sensitive K+ channel
  • Gut hormones (incretins) act as potentiators; presence/anticipation of food = secretion of incretins into circulation which have positive effect on insulin secretion of the β-cell to cope with imminent food intake; forming part of the enteroinsular axis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How can an earlier peak/higher level of insulin in oral glucose be explained in relation to IV glucose (which has much quicker access to the blood thus β-cells)?

A
  • As 60% post-meal insulin secretion is due to incretins (released from gut)
  • Incretins prepares body for anticipation of increase in glucose with a meal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is glucagon’s role in potentiating insulin release?

A

Paracrine communication (affecting neighbouring cells without entering blood) of glucagon released from α cells, increases insulin release.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Where is somatostatin secreted and what is its effect on insulin release?

A
  • δ-cells of Islets of Langerhans

- Inhibitory effect on insulin release (and glucagon release of α cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are some examples of insulin-potentiating incretins/gut hormones?

A
  • Glucagon-like peptide 1 (GLP-1)

- Gastric inhibitory polypeptide (GIP)

20
Q

What is the effect of insulin release upon activation of muscarinic receptors of the β-cell?

A

Parasympathetic stimulation results in a stimulation of insulin release (parasympathetic = rest & digest)

21
Q

What are the effects of sympathetic stimulation on insulin release?

A
  • α2-adrenoceptors predominate over β-adrenoceptors on the β-cell
  • α2 stimulation = inhibition of insulin release (fight or flight)
  • β-adrenoceptor stimulation = stimulatory (but very few on Islet β-cell)
22
Q

What are the main actions of insulin?

A
  • Promotes uptake and utilisation of glucose in skeletal muscke & adipose (fat tissue)
  • Promotes fuel storage; anabolic effect, increasing rate of synthesis and storage of energy reserves (glycogen & fats) and of protein in skeletal muscle
23
Q

What are the ‘other’ actions of insulin?

A
  • Promote growth & development (important in intra-uterine growth factor)
  • Promotes cellular uptake of K+ (via Na+/K+ATPase pump)
24
Q

What is the effect of insulin on skeletal muscle?

A
  • Increase glucose uptake (via GLUT-4 glucose transporter; expressed more in high insulin concentration)
  • Increase protein synthesis using glucose; transformed to AAs/protein
  • Decreases breakdown of protein = anabolic effect
25
Q

What is the effect of insulin on adipose tissue?

A
  • Increase glucose uptake via GLUT-4 to allow fat cells to take up glucose
  • Stimulates lipogenesis (triglyceride production)
  • Decreases lipolysis; anabolic effect of building up triglycerides in adipose tissue
26
Q

What is the effect of insulin in the liver?

A
  • Increase glycogen synthesis (store of carbohydrates)
  • Decrease glycogen breakdown
  • Decrease gluconeogenesis (de novo synthesis of glucose from intermediates such as AAs/lactate/glycerol)
27
Q

What is the only hormone in the body able to lower blood glucose levels?

A

Insulin; hence diabetes mellitus w/o insulin control.

28
Q

What type of receptor is the insulin receptor?

A

Tyrosine kinase linked receptor

29
Q

What occurs at a tyrosine kinase receptor (insulin/EGF) upon hormone binding?

A
  • Ligand (hormone) binds to receptor
  • Intrinsic tyrosine kinase enzyme phosphorylates (adds phosphate groups) itself/target protein
  • Adaptor proteins recognise the phosphorylated receptor and produces multiple signals, including gene expression changes
30
Q

What happens at the insulin receptor (tyrosine kinase type) upon binding with reference to the adaptor protein IRS?

A
  • Insulin binds
  • Autophosphorylation of receptor
  • Makes intracellular portion of receptor (now phosphorylated) much more attractive to adaptor proteins
  • IRS is attracted to phosphorylated portion of receptor and itself becomes phosphorylated
  • pIRS attracts PI 3-kinase enzyme
  • PI 3-kinase goes on to catalyse (another phosphorylation) conversion of PIP2 to PIP3 (phosphatidylinositol(4,5) bisphosphate to phosphatidylinositol(3, 4, 5) triphosphate)
  • PIP3 (phosphatidylinositol(3, 4, 5) triphosphate) goes on to activate another kinase; PDK 1/2
  • PDK 1/2 activates Protein Kinase B (PKB/Akt) which brings about: glucose uptake, protein synthesis, glycogen synthesis, anti-lipolysis (METABOLIC SIGNAL)
31
Q

What happens at the insulin receptor (tyrosine kinase type) upon binding with reference to the adaptor protein Shc

A
  • Insulin binds
  • Autophosphorylation of receptor
  • Intracellular portion of receptor (now phosphorylated) now much more attractive to adaptor proteins; Shc
  • Shc attracted to phosphorylated portion of receptor and itself becomes phosphorylated
  • pShc now attractive to further adaptor proteins; Grb2 and SOS
  • These activate the MAP Kinase cascade (SOS > Ras/Raf-1 > MEK > MAPK); cell survival/proliferation
  • GROWTH SIGNAL
32
Q

What type of inhibitory hormone is somatostatin?

A

Global; inhibits most hormone secretions in the body; glucagon and insulin secretion within the Islets.

33
Q

How many AAs is somatostatin composed of/where is it synthesised?

A
  • 14 AAs

- Synthesised in islet δ-cells (but also in CNS & GI tract)

34
Q

How many AAs is glucagon/where is it synthesised?

A
  • 29 AAs

- Islet α-cells

35
Q

What regulates glucagon release?

A
  • Stimulated by low blood glucose (
36
Q

What are the actions of glucagon?

A

Raise blood glucose:

  • Stimulates hepatic glycogenolysis (breakdown of glycogen)
  • Stimulates hepatic gluconeogenesis (glucose production from intermediates)
  • Stimulates lipolysis (breakdown of fats to fatty acids/glycerol; intermediates undergo gluconeogenesis to glucose)
37
Q

What is meant by the complementary interaction of glucagon and insulin?

A

E.g. with high blood glucose, there is less α-cell stimulation thus less glucagon secretion (that would raise blood glucose), whilst there is more β-cell stimulation leading to an increase in insulin secretion, thus blood glucose drops to normal.

38
Q

What is the normal range of glucose in the blood and how is it maintained?

A
  • 4 - 8mmol/L
  • balance of glucose production (glucagon/adrenaline/growth hormone/cortisol) vs. utilisation (insulin)
  • counter-regulatory to each other
39
Q

What is the role of adrenaline and glucose production?

A
  • Provision of energy for emergencies and excercise

- Kicks in with severe hypoglycaemia (helping glucagon raise blood glucose much more rapidly)

40
Q

What is the role of cortisol and glucose production?

A
  • Mobilising fuel during stressful situation; more energy available to adapt and deal with
  • Secreted in prolonged hypoglycaemia to help raise blood glucose
41
Q

What is the role of growth hormone and glucose production?

A
  • Promotion of growth (normally smaller role in metabolism)

- Secreted in prolonged hypoglycaemia to help raise blood glucose

42
Q

What are the effects of insulin on glycogenolysis, gluconeogenesis (production) and glucose uptake/use (utilisation in adipose/skeletal muscle)?

A
  • Decreased glycogenolysis
  • Decreased gluconeogenesis
  • Increased uptake/use
43
Q

What are the effects of glucagon on glycogenolysis, gluconeogenesis (production) and glucose uptake/use (utilisation in adipose/skeletal muscle)?

A
  • Increased glycogenolysis
  • Increased gluconeogenesis
  • No effect on glucose uptake/use in adipose/skeletal muscle
44
Q

What are the effects of adrenaline/NA on glycogenolysis (which receptors?), gluconeogenesis (production) and glucose uptake/use (utilisation in adipose/skeletal muscle)?

A
  • Increased glycogenolysis via α1 and β2 adrenoceptors
  • Indirectly increased gluconeogenesis (mobilisation of glycerol & non-esterified fatty acids)
  • Decreased uptake/use in adipose/skeletal muscle
45
Q

What are the effects of growth hormone on glycogenolysis, gluconeogenesis (production) and glucose uptake/use (utilisation in adipose/skeletal muscle)?

A
  • No effect on glycogenolysis
  • Indirectly increased gluconeogenesis (mobilisation of glycerol & non-esterified fatty acids)
  • Decreased glucose uptake/use in adipose/skeletal muscle
46
Q

What are the effects of cortisol on glycogenolysis, gluconeogenesis (production) and glucose uptake/use (utilisation in adipose/skeletal muscle)?

A
  • No effect on glycogenolysis
  • Increased gluconeogenesis
  • Decreased glucose uptake/use